GPM6A gene
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| GPM6A | expressed_in | central nervous system | — | 1 |
| GPM6A | expressed_in | CNS | — | 1 |
| GPM6A | biomarker_for | CNS | — | 1 |
| GPM6A | associated_with | doxycycline | — | 1 |
| GPM6A | risk_factor_for | schizophrenia | — | 1 |
| GPM6A | expressed_in | spinal cord | — | 1 |
Mentioned in (2)
Papers in which this entity is mentioned.
- Mapping genomic loci implicates genes and synaptic biology in schizophrenia. (2022)
- NGN2 induces diverse neuron types from human pluripotency. (2021)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| gpm6a | gene | 2 | 7 |
| gpm6a+ | gene | — | — |
| gpm6a positive | gene | — | — |